Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2012, Article ID 535709, 6 pages
Review Article

JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms

Department of Hematology, Erasmus University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands

Received 12 September 2011; Revised 29 November 2011; Accepted 4 December 2011

Academic Editor: Mark R. Litzow

Copyright © 2012 Mar Bellido and Peter A. W. te Boekhorst. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Carmela Fimognari, Lorenzo Ferruzzi, Eleonora Turrini, Giovanni Carulli, Monia Lenzi, Patrizia Hrelia, and Giorgio Cantelli-Forti, “Metabolic and toxicological considerations of botanicals in anticancer therapy,” Expert Opinion On Drug Metabolism & Toxicology, vol. 8, no. 7, pp. 819–832, 2012. View at Publisher · View at Google Scholar
  • Eleonora Turrini, Lorenzo Ferruzzi, and Carmela Fimognari, “Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy,” Oxidative Medicine and Cellular Longevity, vol. 2015, pp. 1–19, 2015. View at Publisher · View at Google Scholar